MROSS, Klaus et al.
 Phase I study of telatinib (BAY 57-9352): analysis of safety, pharmacokinetics, tumor efficacy, and biomarkers in patients with colorectal cancer.
<strong>Vascular Cell</strong>, [S.l.], v. 3, n. 1, p. 16, july 2011.
ISSN 2045-824X.
Available at: &lt;<a href="https://vascularcell.com/index.php/vc/article/view/10.1186-2045-824X-3-16" target="_new">https://vascularcell.com/index.php/vc/article/view/10.1186-2045-824X-3-16</a>&gt;. Date accessed: 18 jan. 2025.
doi: <a href="http://dx.doi.org/10.1186/2045-824X-3-16">http://dx.doi.org/10.1186/2045-824X-3-16</a>.